ANAHEIM, Calif. – More than 100 years ago, physician Alois Alzheimer uncovered a disease that robbed the elderly of the ability to think and function in everyday life. Today the disease that carries his name affects an estimated 5.3 million Americans who struggle to preserve their quality of life each and every day.
“Alzheimer’
Alzheimer’s is a progressive and fatal brain disorder that destroys brain cells that reduces the patient’s ability to think, reason, recall facts and maintain a normal life. It is the most common form of Dementia accounting for 50 to 70 percent of all cases. It also currently does not have a cure.
South Coast Clinical Trials has partnered with local Neurologist Dr. Karen Frei, MD to work closely with Alzheimer patients.
“We are working very closely with local Alzheimer patients to not only try to help find a cure to this debilitating disease, but also ensure that they are receiving the proper care to help them manage their lives,” Dr. Frei said.
In fact, progress has been made on treatments for Alzheimer’s disease thanks to participation in the clinical trial process. South Coast Clinical Trials is a leader in Alzheimer’s clinical trials and follows it up with the great after care program that far exceeds the industry standards.
“At South Coast Clinical Trials, we have built a strong reputation for care before, during and after the clinical trial process,” Dr Frei said. “We pride ourselves on care for the entire individual, including access to social workers, support groups, day treatment centers and even group homes to help patients maintain their quality of life.”
For more information on South Coast Clinical Trials, or to get information about their Alzheimer’s disease clinical trial and after care programs, please visit them on the Internet at www.southcoastclinicaltrials.com.
About South Coast Clinical Trials
South Coast Clinical Trials, Inc is a dedicated Southern California research facility founded in 2001 by Dr. Adonis Sfera, MD that specializes in psychiatric and neurological clinical trials.
We are dedicated to assisting in the process of developing and implementing new study drugs to the marketplace, while maintaining participant safety and satisfaction exceeding the industry standard. We specialize in central nervous system disorders, which include Schizophrenia Bipolar Disorder, Major Depression, and Alzheimer’s Disease etc.
To date, we have worked with various sponsors including AstraZeneca, Pfizer, Merck, Solvay, Johnson & Johnson, Quintiles, Kendle, Myriad, PPD, PRA, DSP, Takeda, UBC, Wyeth, and Novartis, among others.
For more information about South Coast Clinical Trials, please visit us on the Internet at http://www.southcoastclinicaltrials.com.
-30-
Media Contact:
Dan Sfera
South Coast Clinical Trials, Inc.
Email: dan@southcoastclinicaltrials.com
Phone: 888-269-5759
